about
Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients.RC-3095, a selective gastrin-releasing peptide receptor antagonist, does not protect the lungs in an experimental model of lung ischemia-reperfusion injury.Role of biomarkers in early infectious complications after lung transplantation.Incidence and Risk Factors of Abdominal Complications After Lung Transplantation.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Update in lung transplantation 2013.
@ast
Update in lung transplantation 2013.
@en
Update in lung transplantation 2013.
@nl
type
label
Update in lung transplantation 2013.
@ast
Update in lung transplantation 2013.
@en
Update in lung transplantation 2013.
@nl
prefLabel
Update in lung transplantation 2013.
@ast
Update in lung transplantation 2013.
@en
Update in lung transplantation 2013.
@nl
P2860
P1476
Update in lung transplantation 2013.
@en
P2093
Jamie L Todd
Scott M Palmer
P2860
P356
10.1164/RCCM.201402-0384UP
P407
P577
2014-07-01T00:00:00Z